Sign in

CIK 0001768446

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Climb Bio, Inc.

Sign in to watch
Ticker
CLYM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
832273741
Phone
+1 866-857-2596
Business address
20 WILLIAM STREET, SUITE G50, WELLESLEY HILLS, MA
Former names
Eliem Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,366,820
in 1 filing, $1.4M under 10b5-1 plans

Net −$1,366,820. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Thomas Stephen Basil −$1.4M Director sold 18% of stake
Date Insider Transaction Shares Price Value Owned after
2026-06-05 WILLIAMS DOUGLAS E Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2025-06-04 WILLIAMS DOUGLAS E Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2025-03-31 WILLIAMS DOUGLAS E Director Grant or award · Stock Option (Right to Buy) +78,873 78,873
2024-11-11 WILLIAMS DOUGLAS E Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2024-11-11 WILLIAMS DOUGLAS E Director Grant or award · Stock Option (Right to Buy) +6,291 6,291

Page 1 of 1 · 5 trades